Latest News Archive
Please select Category, Year, and then Month to display items
22 February 2018
Photo Thabo Kessah
Pakiso Mthembu will be representing South Africa in Mauritius and Algeria.
This year, the University of the Free State’s Qwaqwa Campus will unleash a running sensation that is equally comfortable on track, cross-country, and road running and is on a mission to conquer the world. His name is Pakiso Mthembu from Tweeling in the Eastern Free State. Pakiso has recently qualified for the Junior Men’s Southern Region cross-country championships that will be held in Mauritius on 24 February and in Algeria on 17 March 2018.
“I am glad that I managed to run my personal best time of 24:02 during the qualification trials held in Bloemfontein in January, which set me on the road to Mauritius and Algeria,” said Pakiso, a BEd FET first-year student.
His personal best in the 10 km road-running category and in the 5 000 m track are 30:55 and 14:29, respectively.
Praise for Soke
“It is only through dedication, hard work, and listening to my coach that I can achieve my dreams of representing South Africa at the International Association of Athletics Federations World Junior Championships (IAAF) to be held in Finland in July, and at the 2020 Tokyo Olympics. I have one of the best coaches in this part of the world and it gives me great pleasure to work with him, having grown up admiring him during his days,” he says in reference to Boy Soke, who identified his talent and recruited him to the Qwaqwa Campus.
Pakiso has already represented South Africa in Uganda.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004